Approximately 20-25% of all cancers result from infectious agents, with the majority of these malignancies being virus-associated cancers. The Virology Program focuses on deciphering the basic mechanisms related to how human tumor viruses are linked to the development of malignancies with the goal of generating new specific therapies for cancer and for vaccines against these viruses. There are five programmatic themes in the Virology Program. These include (i) Viruses and Immunity (ii) Virus-Cell Interactions (iii) Viral Pathogenesis and Tumorigenesis (iv) AIDS-associated cancers and (v) Clinical & Translational Virology. These themes address the effects of viral infection on innate immunity and inflammation and the mechanisms by which viruses promote tumorigenesis with the ultimate goal being to develop new therapies for treating viral cancers and vaccines against oncogenic viruses. Some discoveries include the finding that virus-infected cells secrete exosomes which modulate the tumor environment, that viral-encoded microRNAs contribute to the development of neoplasms, that oncogenic viruses can blunt innate immune recognition by the host cell, and that new therapies for AIDS-associated cancers targeting cell signaling pathways are efficacious. The program is jointly led by Nancy Raab-Traub, PhD, Sarah Graham Kenan Professor of Microbiology & Immunology who is world renowned for her work on Epstein-Barr virus and associated cancers, and Blossom Damania, PhD, Assistant Dean of Research and Professor of Microbiology & Immunology, whose expertise on innate immunity and oncogenic viruses is well recognized. There are 19 program members from 6 different departments across campus. The Virology Program has recruited three new faculty since 2010: Cary Moody, Nat Moorman and Stan Lemon. During the last funding period, program members have published 343 cancer-related articles (24% collaborative). In 2014, our program members held 58 grants and $18.9M (total cost) in annual extramural funding, including 21 grants and $6M (total costs) from the NCI.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Kwo, Paul; Fried, Michael W; Reddy, K Rajender et al. (2018) Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort. Hepatol Commun 2:354-363
Dunn, Julia L M; Kartchner, Laurel B; Gast, Karli et al. (2018) Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury. J Leukoc Biol 103:909-918
Kolupaev, Oleg V; Dant, Trisha A; Bommiasamy, Hemamalini et al. (2018) Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD. Blood Adv 2:2307-2319
Beckford Vera, Denis R; Smith, Christof C; Bixby, Lisa M et al. (2018) Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors. PLoS One 13:e0193832
McLamarrah, Tiffany A; Buster, Daniel W; Galletta, Brian J et al. (2018) An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly. J Cell Biol 217:1217-1231
Sanoff, Hanna K (2018) Best Evidence Supports Annual Surveillance for Resected Colorectal Cancer. JAMA 319:2083-2085
Chiou, Yi-Ying; Hu, Jinchuan; Sancar, Aziz et al. (2018) RNA polymerase II is released from the DNA template during transcription-coupled repair in mammalian cells. J Biol Chem 293:2476-2486
Corbie-Smith, Giselle; Wynn, Mysha; Richmond, Alan et al. (2018) Stakeholder-driven, consensus development methods to design an ethical framework and guidelines for engaged research. PLoS One 13:e0199451
Dunn, Julia L M; Kartchner, Laurel B; Stepp, Wesley H et al. (2018) Blocking CXCL1-dependent neutrophil recruitment prevents immune damage and reduces pulmonary bacterial infection after inhalation injury. Am J Physiol Lung Cell Mol Physiol 314:L822-L834
Xiao, Weidong; Gao, Guangping; Ling, Chen et al. (2018) Impact of neutralizing antibodies against AAV is a key consideration in gene transfer to nonhuman primates. Nat Med 24:699

Showing the most recent 10 out of 1525 publications